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Abstract 
In mammalian cells, the basal Na+-dependent uptake for many of the neutral amino acids is mediated by a transport activity 
designated System ASC. A cloned human brain cDNA sequence, ASCTI, encodes aNa+-dependent neutral amino acid transport activity 
that exhibits a substrate specificity similar to that commonly associated with System ASC. However, the characteristics of ASC activity 
varies significantly between cell types and not all tissues contain detectable l vels of ASCTI mRNA. A unique property of System ASC 
activity is an altered substrate selectivity such that at pH values below 7.4 anionic amino acids function as inhibitors and substrates. The 
experiments in this report were designed to determine if the cloned ASCT1 transporter exhibited this pH-dependent anionic transport. 
Following transfection of HeLa cells with the ASCTI cDNA, transport strongly favored neutral zwitterionic) amino acids when uptake 
was measured at a physiologic pH value of 7.5. However, lowering the assay pH to 5.5 significantly enhanced the interaction of the 
ASCT1 carrier with anionic amino acids such as cysteate, in a pH-dependent manner. The apparent pK for the titratable group was in the 
range of 6.5-7.0. These results provide evidence that the human brain ASCT1 transporter exhibits the most distinguishing characteristic 
known for System ASC and provides a model system to investigate the molecular basis for this shift in substrate acceptance. 
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1. Introduction 
The concentrative uptake of amino acids across the 
plasma membrane is mediated by alkali ion-driven trans- 
porters which exhibit overlapping substrate specificities 
[1,2]. These activities have been extensively characterized 
in tissues, whole cells, and plasma membrane vesicles [3]. 
Until recently, little molecular characterization of these 
transporters has been possible due to the lack of cDNA 
probes or antibodies. Two cDNA sequences ASCT and 
SATT) that had homology to a family of Na+-dependent 
glutamate transporters [4-6], were independently cloned 
from human hippocampal cDNA libraries [7,8]. Although 
they were originally considered to be two different amino 
acid sequences, most of the differences have been resolved 
Abbreviations: cholKRP, choline-containing Krebs Ringer phosphate 
buffer (Na + free buffer); MeAIB, 2-(methylamine)isobutyric acid; 
NaKRP, sodium-containing Krebs Ringer phosphate buffer; PMSF, 
phenylmethylsulfonyl fluoride; TPCK, tosylphenylalanine chloromethyl 
ketone; TLCK, tosyllysine chloromethyl ketone; C~2E 9, polyoxyethyl- 
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and the term ASCT1 has been adopted by Shafqat et al. 
[9]. Recently, the ASCTI gene has been localized to 
human chromosome 2pl 3-pl 5 [ 10]. 
It was proposed that the ASCTI clone encoded the 
human brain ASC transport activity, largely on the basis of 
increased Na+-dependent uptake of substrates typical of 
System ASC by ASCT1 [7,8]. System ASC activity is 
expressed in most, if not all, mammalian cells. It mediates 
the basal uptake of a wide range of neutral amino acids, 
but exhibits a preference for those with hydroxyl- or 
sulfhydryl-containing sidechains uch as serine, cysteine, 
and threonine [11,12]. Although System ASC has been 
considered a single activity, significant issue variation in 
the most basic properties such as the range of neutral 
amino acid substrates and the acceptance of Li + to substi- 
tute for Na + is also consistent with the hypothesis that 
ASC activity is mediated by different proteins in different 
tissues [11-15]. A number of tissues do not contain de- 
tectable ASCTI mRNA by Northern analysis [7,8], despite 
having measurable ASC transport activity. These results 
could be due to: (1) an ASCTI mRNA level below the 
sensitivity of Northern analysis; (2) related genes encoding 
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similar activities, but sufficiently different in sequence to 
escape hybridization at high stringency (although attempts 
to screen cDNA libraries from these tissues at low strin- 
gency has not revealed such sequences); or (3) ASC-like 
activity resulting from expression of unrelated genes in a 
tissue-specific manner. A similar circumstance exists for 
the glutamate transporters in that there is cell specific 
expression of four different genes [4-6,16]. Therefore, 
Northern analysis of a given cell type might reveal the lack 
of a particular transporter mRNA, despite the presence of 
Na+-dependent glutamate transport activity. By analogy, it 
is likely that ASCT1 represents one of a family of related 
genes that code for a similar transport activity and the 
other members have yet to be identified. If this is the case, 
the transport properties of the brain ASCTl-encoded pro- 
tein may or may not correspond to those previously de- 
scribed for System ASC in other tissues. 
The most unique feature reported for System ASC is a 
pH-dependent alteration of substrate selectivity [17-19]. 
When assayed at neutral pH, System ASC primarily medi- 
ates the uptake of neutral amino acids, whereas at an acidic 
pH (< 7.0) both neutral and anionic amino acids are 
effective inhibitors and substrates. Given that previous 
reports relied almost solely on neutral amino acid uptake at 
pH 7.5 to assign ASC activity to the ASCT1 clone, the 
present experiments were designed to determine if the 
human hippocampal ASCT1 transporter xhibited a pH-de- 
pendent change in reactivity with anionic amino acids. The 
anionic amino acid analog cysteate was chosen as a test 
inhibitor because its sidechain pK of less than 1.5 elimi- 
nates titration of the inhibitor to a zwitterion as a possible 
interpretation. The data demonstrate that brain ASCTI- 
mediated uptake is not functional in the presence of Li + 
instead of Na ÷ and is inhibited by cysteate in a pH-depen- 
dent manner. The observed acceptance of anionic amino 
acids in the presence of a decreased extracellular pH may 
help to explain the apparent evolutionary relationship be- 
tween ASCT1 and the four previously identified numbers 
of the so-called 'glutamate transporter family' [4-6,16]. 
plasmid without insert, or the ASCT1 sequence in the 
anti-sense orientation, was used in control transfections to
demonstrate hat the infection/transfection process itself 
did not induce an endogenous transport activity. 
2.2. Transport assays 
8 h post-transfection the cells were washed twice in 2 
ml/well of Na+-free Krebs Ringer phosphate buffer 
(cholKRP) at 37°C, each of the Na ÷ salts was replaced 
with the corresponding choline salts [20]. The uptake of 5 
/xM [3H]serine (Amersham Corp., Arlington Heights, IL) 
was initiated by the addition of 250 /~1 of uptake 
buffer/well at 37°C, as described previously [20]. The 
uptake buffer, either NaKRP (Na+-containing buffer) or 
cholKRP, always contained 2 mM MeAIB, a System 
A-specific analog to eliminate contribution of that activity 
to the uptake of the test amino acid [21]. The Na+-depen - 
dent transport was calculated as the difference in uptake in 
Na+-containing (NaKRP) and Na+-free cholKRP) medium 
and is reported as the averages +__ S.D of at least four 
determinations. All variables and the appropriate controls 
were contained within a given experiment and each experi- 
ment was repeated with multiple cell preparations to 
demonstrate qualitative reproducibility. 
2.3. Northern analysis 
The method of Chomczynski and Sacchi was used to 
prepare total cellular RNA [22] and poly(A) mRNA was 
isolated by the PolyATract system according to the manu- 
facturer's protocol (Promega, Madison, WI). ASCT1 
mRNA content was detected by Northern analysis as de- 
scribed by Church and Gilbert [23]. Following UV cross- 
linking to a nylon membrane, the RNA was hybridized at 
65°C with a cDNA probe for either ASCT1 or /3-actin, 
radioactively abelled prior to hybridization with [ 32 P]dCTP 
using a random primer DNA labelling kit (BRL, Gaithers- 
burg, MD). Blots were subjected to autoradiography. 
2. Methods 
2.1. Cell transfection 
HeLa cells were maintained in tissue culture and trans- 
porter cDNA expression was performed as described previ- 
ously [8]. Approx. 100000-150000 cells/well in 24-well 
cell culture plates were infected with a recombinant vac- 
cinia virus strain VTF7_ 4 15 plaque forming units/cell) 
that expresses T7 polymerase. Using 3 /xl/well of lipo- 
fectin (BRL, Gaithersburg, MD), 30 min after virus infec- 
tion the cells were transfected with 1 /zg/well of the 
plasmid vector pcDNA3 alone (Invitrogen, San Diego, 
CA) or plasmid containing the full-length ASCT1 insert 
cloned downstream of a T7 promoter sequence [8]. The 
2.4. lmmunoblotting of ASCT1 transport protein 
To detect he ASCT1 protein by immunoblotting, the 
DNA sequence corresponding to the FLAG epitope se- 
quence DYKDDDDK was subcloned between amino acid 
residues 477 and 478 to generate an ASCT1/FLAG con- 
struct. This epitope is recognized by a commercially-avail- 
able (Kodak Co., New Haven, CT) monoclonal antibody 
[24]. In parallel transfections for both transport and protein 
measurements, cells were extracted in 0.2 N NaOH/0.2% 
SDS and then 10 /zg protein per lane was subjected to 
one-dimensional sodium dodecylsulfate polyacrylamide g l 
electrophoresis [25,26], transferred to nitrocellulose [26], 
and the transporter protein detected by enhanced chemilu- 
minescence (Amersham Corp., UK) immunoblotting ac- 
cording to the manufacturer's directions. The anti-FLAG 
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antibody was used at 10 /zg/ml and rabbit anti-mouse 
linked to horseradish peroxidase (1:20000) was the sec- 
ondary antibody. 
3. Resul ts  
A 
HeLa cells or Xenopus oocytes that express the ASCT1 
transporter xhibit a significant increase in the Na+-depen - 
dent uptake of serine, threonine, and cysteine that is not 
blocked by the System A specific analog MeAIB [7-9]. 
We have documented the expression of the corresponding 
ASCTI mRNA by Northern analysis following transfec- 
tion of HeLa cells with pcDNA3 plasmid alone or plasmid 
containing the ASCT1 insert (Fig. 1A). Endogenous 
ASCT1 mRNA, if expressed at all in HeLa cells, was not 
detectable, whereas an intense signal was obtained from 
ASCT1 transfected cells. 
To demonstrate the expression of the ASCT1 trans- 
porter protein itself HeLa cells were transfected with a 
cDNA construct in which the FLAG epitope sequence was 
inserted to permit detection with the FLAG monoclonal 
ant ibody [24]. This ep i tope- tagged protein 
(ASCT1/FLAG) yielded approximately the same level of 
5 /zM [3H]serine transport as the native sequence 
(ASCTl-Mediated = 452 + 48, ASCT1/FLAG-Mediated 
= 551 ± 51 pmol serine/mg protein per min). In two 
separate xperiments, immunoblotting of a total cell ex- 
tract from cells transfected with the ASCT1/FLAG con- 
struct revealed a significant amount of protein expression 
(Fig. 1B). At the present ime, the molecular basis for the 
multiple bands is unknown, but similar patterns for both 
endogenous and expressed transporters have been shown 
to be due to heterogeneity in glycosylation. Cells trans- 
fected with the native ASCT1 cDNA served as the nega- 
tive control and no immunoreactive protein was observed. 
Parallel experiments in which protein expression was mea- 
sured instead by immunoprecipitation of 35S-labelled cells 
using anti-FLAG antibody showed a similarly broad band 
of immunoreactive protein in the same size range (60-70 
kDa) as that obtained by immunoblotting data not shown). 
Shafqat et al. [8] previously demonstrated that ASCT1- 
mediated serine uptake was unaffected by the replacement 
of chloride in the uptake buffer with anions such as 
thiocyanate, gluconate, or acetate. With regard to the 
co-transported cation, the ability of System ASC to accept 
Li+-for-Na + substitution varies widely between cell types. 
For example, in Ehrlich ascites cells [11,13] and certain 
hepatoma cell lines [12] Li ÷ is not an effective co-sub- 
strate for System ASC but in rat hepatocytes a significant 
amount of Li+-dependent ASC activity is measurable 
[14,15]. As shown in Table 1, the human brain-derived 
ASCT1 transporter was completely inactive when Na ÷ 
was replaced with Li +. 
The System ASC activity in Ehrlich ascites tumor cells 
and rat hepatocytes was shown to exhibit a unique pH-de- 
ASCT1 
ACTIN 
B 
kDa 
86 - 
51 - -  
19--- 
¢aej ¢a~ 
Fig. l. ASCT1 mRNA and protein content in transfected HeLa cells (A) 
Poly(A) mRNA was isolated from HeLa cells 8 h after they were 
transfected with pcDNA3 containing the ASCTI cDNA or pcDNA3 
plasmid only. The mRNA (2 /zg/lane) was subjected to Northern 
analysis with 32P-labelled ASCT1 cDNA. Exposure time for the blot 
shown was approx. 30 rain. Ethidium bromide staining of the rRNA 
bands and the /3-actin mRNA content served as internal references for 
comparison of the RNA loaded in each lane. (B) HeLa cells were 
solubilized in 0.2 N NaOH/0.2% SDS 8 h after they were transfected 
with ASCTI cDNA or the ASCT1/FLAG cDNA containing the 8 amino 
acid FLAG insertion after residue 477. The ASCTI /FLAG transporter 
was detected by immunoblotting following one-dimensional SDS-PAGE 
using the FLAG monoclonal antibody as described in Section 2. Expres- 
sion of protein in two independent experiments is shown (ASCT1/FLAG 1 
and ASCT1/FLAG2). Where not shown, the standard eviation bars are 
contained within the symbol. 
pendent alteration of substrate specificity that converted 
the transporter f om one that accepts only neutral amino 
acids to one that also exhibits affinity for anionic sub- 
strates [17-19]. Inhibition or transport of anionic amino 
acids that have sidechain pK values of less than 1.5, such 
as cysteate and cysteinesulfinate, has demonstrated that 
this pH effect on System ASC was associated with titration 
of the transporter rather than the substrate [18,19]. To 
determine if the human hippocampal ASCT1 transporter 
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Table 1 
Effect of cation substitution on ASCTl-mediated serine uptake 
Cation Serine uptake (pmol/mg protein per min) 
control transfected 
NaKRP 380 -+_ 56 782 + 70 ( P < 0.005) 
LiKRP 38-+ 12 34+ 14 (N.S.) 
CholKRP 22+ 4 38-+ 12 (P < 0.05) 
8 h after transfection, the MeAIB-insensitive uptake of 5 #M [3H]serine 
was measured for 1 min at 37°C in NaKRP, cholKRP, or LiKRP. The 
control cells were transfected with pCDNA3 vector alone. The data are 
reported as the averages+S.D, of at least four determinations, The 
indicated P values were determined by the Student's t-test. For each 
medium, the transport rates in the ASCTl-transfected cells were com- 
pared to those cells obtained with cells transfected with plasmid only. 
Several replicate experiments with different cell preparations yielded 
similar results. (N.S. = not statistically different). 
exhibited a pH-dependent acceptance of anionic amino 
acids, ASCT l -med ia ted  serine uptake was assayed at pH 
7.5 or 5.5 in the presence of  increasing amounts of  unla- 
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Fig. 2. Concentration-dependence of ysteate inhibition of ASCTl-media- 
ted serine uptake Sodium-dependent uptake of 5 /zM [3H]serine, in the 
presence of 2 mM MeAIB, was measured for 1 min at 37°C at pH 7.5 (A) 
or pH 5.5 (B). ASCTl-mediated uptake was obtained by subtracting the 
Na+-dependent uptake in cells transfected with vector only from that in 
cells transfected with ASCT1 cDNA at each concentration. The concen- 
tration of unlabelled serine or cysteate as inhibitor was varied from 0 to 2 
mM as shown, The data are the averages of assays in triplicate, and 
repetitive xperiments with different cell preparations yielded qualita- 
tively similar results. Where not shown, the standard eviation bars are 
contained within the symbol. The control velocities corresponding to 
100% were 600+ 10 and 300+ 17 pmol/mg protein per min at pH 7.5 
and 5.5, respectively. 
~" lO0 
® 50 /<>_...o 
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Fig. 3. The pH-dependent inhibition of ASCTl-mediated serine uptake by 
cysteate Inhibition of the MeAIB-insensitive ASCTl-mediated uptake of 
5 /xM [3H]serine was measured in the presence and absence of 2 mM 
cysteate for 1 min at 37°C. The Na+-dependent transport rates in cells 
transfected with plasmid only were subtracted from those transfected with 
plasmid containing ASCT1 to obtain the values shown. The pH of the 
transport assay medium was varied between 5.5 and 8.0. The control 
velocity, ASCTl-mediated serine uptake at pH 7.5 in the absence of 
cysteate, was 600+ 10 pmol/mg protein per rain. Where not shown, the 
standard eviation bars are contained within the symbol. 
belled cysteate or serine itself (Fig. 2). At pH 7.5, cysteate 
produced only modest inhibition at concentrations up to 1 
mM, whereas unlabelled serine completely saturated its 
own transport at 1 mM (Fig. 2A). However,  at pH 5.5, the 
inhibition of serine uptake by cysteate was half -maximal at 
approx. 100 /xM and was nearly complete at a concentra- 
tion of 1 mM (Fig. 2B). Inhibition by the anionic amino 
acids, aspartate, glutamate, and cysteinesulf inate gave sim- 
ilar results (data not shown). 
To establish the pH-dependent profi le for the substrate 
conversion of  the ASCT1 transporter, transfected cells 
were tested for inhibition of  serine uptake by 2 mM 
cysteate at several assay pH values between 8.0 and 5.5. 
At pH 7.5, ASCT l -med ia ted  serine uptake was inhibited 
by less than 20% in the presence of  cysteate (Fig. 3). 
However,  as the extracellular pH was decreased, the 
cysteate inhibition of  ASCT l -med ia ted  serine uptake in- 
creased until the serine transport was completely abolished 
at pH 5.5. The data obtained suggest titration of  a group 
with a pK  value of  approx. 6.5-7.0.  The most l ikely 
residue to account for this response is a histidine for which 
the imidazole group has a pK  value of  about 6.0 when 
determined as a free amino acid in solution. 
4.  D iscuss ion  
The ASCT1 transporter cloned from human hippocam- 
pus mediates the uptake of  neutral amino acids such as 
alanine, serine, threonine, and cysteine [7,8]. Based on this 
substrate specificity and a few other features, the ASCT1 
clone was proposed to code for a transport activity origi- 
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nally described 3 decades ago and called System ASC [11]. 
System ASC is a generic term for similar activities in a 
wide variety of mammalian cells, but significant differ- 
ences between cell types have been noted [12]. In a few 
cell lines, a unique characteristic of System ASC is a novel 
pH-dependent alteration of its substrate specificity [18,19]. 
The results reported here show that the human brain 
ASCTI transporter exhibits this property. The present 
investigation, as well as the original reports of this phe- 
nomenon, have used amino acids with sidechain pK val- 
ues of less than 1.5 to document hat titration of the 
transporter rather than the substrate is responsible for the 
acceptance of the anionic amino acid. Interestingly, serine 
itself was a more effective inhibitor at pH 5.5, an observa- 
tion consistent with the results of Vadgama and Chris- 
tensen for threonine inhibition of System ASC in Ehrlich 
ascites tumor cells [17]. 
Protonation of a histidine residue would be consistent 
with the pH-dependent profile for this change of substrate 
specificity. For GLT1, one of the glutamate transporters 
related to ASCT1 [7,8], site-directed mutagenesis of histi- 
dine 326 abolished transport [27]. Other transporters for 
which a histidine residue may play a critical role include 
the lactose transporter [28] and the Na+/H + exchanger 
[29] of E. coli, the neuronal monoamine vesicle trans- 
porter [30] and mammalian Ca 2 +-ATPase [31]. Conversion 
of a neutral residue such as histidine to a site of positive 
charge within the ASCT1 protein might provide a recogni- 
tion site for the anionic sidechain. It is interesting to 
speculate that the ability of ASCT1 to undergo this inter- 
convertibility is also reflected in the sequence similarity 
between ASCTI and the numerous glutamate/aspartate 
transporters that have been cloned [4-6,16]. Recently 
[16,32], four human glutamate transporter clones (EAATI- 
4) were reported, three of which are homologs to the rat 
GLAST1 [4], rat GLT1 [5], and rabbit [6] or rat [15] 
EAAC1 clones. The primary amino acid sequence of 
EAAT3 cloned by Arriza et al. [32] is identical to that of a 
human kidney EAAC 1 clone obtained by Kanai et al. [33]. 
Human ASCTI shows 60.7%, 57.0%, and 58.8% homol- 
ogy to the human EAAT1-3 transporters, respectively. 
Beyond the obvious importance of this pH-dependent 
substrate interconversion as an experimental tool to probe 
structure-function relationships within the ASCT1 trans- 
porter protein, this alteration in amino acid recognition 
also may have physiologic significance. ASCTI mRNA is 
expressed at high levels in intestinal tissue [8], and it has 
been demonstrated both in vitro and in vivo that there are 
pH microclimates in specific regions of the intestinal 
mucosa. Lucas [34], using exteriorized rat intestinal loops, 
measured intestinal microvillus surface pH. When incu- 
bated in a medium at pH 7.2, the surface pH in the 
proximal jejunum was 6.1, whereas the surface pH in the 
mid gut was 6.5, and in the distal ileum it was 7.3. 
Causing anoxia of the tissue by blocking blood supply 
caused the surface pH in the jejunum to increase to that of 
the incubation medium. Daniel et al. [35] used microelec- 
trode measurements of rat jejunum in vitro to demonstrate 
that the surface pH was most acidic in a 10-100 /zm 
region just below the tip of the villus, but the surface pH in 
the villus crypt was actually slightly alkaline. In a separate 
study [36], it was shown that this pH gradient, from the 
villus tip to the crypt, occurred in the jejunum, but not in 
the ileum. Those authors also showed that treatment of the 
tissue in situ with theophylline caused an increase in the 
jejunum pH microclimate, suggesting regulation of this pH 
microclimate in response to the metabolic status of the 
animal. If the ASCT1 transporter is expressed in the 
jejunal brush border domain and the acidic microclimate at
the membrane surface permits acceptance of anionic amino 
acids by this transporter, egulation of this microclimate, 
either acutely or chronically, would permit modulation of 
the substrates transported and thus, alter tissue availability. 
Acknowledgements 
These studies were supported by a grant DK-28372) 
from the National Institutes of Health, The Institute for 
Diabetes, Digestive and Kidney Diseases. 
References 
[1] Barker, G.A and Ellory, J.C. (1990) Exp. Physiol. 15, 3-26. 
[2] Cheeseman, C. (1991) Prog. Biophys. Mol. Biol. 55, 71-84. 
[3] Guidotti, G.G. and Gazzola, G.C. (1992) In Mammalian Amino 
Acid Transport (Kilberg, M.S. and H[iussinger, D., eds.), pp. 3-29, 
Plenum Press, New York. 
[4] Storck, T., Schulte, S., Hofmann, K. and Stoffel, W. (1992) Proc. 
Natl. Acad. Sci. USA 89, 10955-10959. 
[5] Pines, G., Danbolt, N.C., Bjoras, M., Zhang, Y., Bendahan, A., 
Eide, L., Koepsell, H., Storm-Mathisen, J., Seeberg, E. and Kanner, 
B.I. (1992) Nature 360, 464-467. 
[6] Kanai, Y. and Hediger, M.A. (1992) Nature 360, 467-471. 
[7] Arriza, J.L., Kavanaugh, M.P., Fairman, W.A., Wu, Y.N., Murdoch, 
G.H., North, R.A. and Amara, S.G. (1993) J. Biol. Chem. 268, 
15329-15332. 
[8] Shafqat, S., Tamarappoo, B.K., Kilberg, M.S., Puranam, R.S., Mc- 
Namara, J.O., Guadano-Ferraz, A. and Fremeau, R.T. (1993) J. Biol. 
Chem. 268, 15351-15355. 
[9] Shafqat, S., Tamarappoo, B.K., Kilberg, M.S., Puranam, R.S., Mc- 
Namara, J.O., Guadano-Ferraz, A. and Fremeau, R.T. (1994) J. Biol. 
Chem. 269, 20208. 
[10] Hofmann, K., Duker, M., Fink, T., Lichter, P. and Stoffel, W. 
(1994) Genomics 24, 20-26. 
[11] Christensen, H.N., Liang, M. and Archer, E.G. (1967) J. Biol. 
Chem. 242, 5237-5246. 
[12] Handlogten, M.E., Garcia-Canero, R,, Lancaster, K.T. and Chris- 
tensen, H.N. (1981) J. Biol. Chem. 256, 7905-7909. 
[13] Christensen, H.N. and Handlogten, M.E. (1978) Biochim. Biophys. 
Acta 512, 598-602. 
[14] Kilberg, M.S., Handlogten, M.E. and Christensen, H.N. (1981) J. 
Biol. Chem. 256, 3304-3312. 
[15] Edmondson, J.W., Lumeng, L. and Li, T.K. (1979) J. Biol. Chem. 
254, 1653-1658. 
[16] Fairman, W.A., Vandenberg, R.J., Arriza, J.L., Kavanaugh, M.P. 
and Amara, S.G. (1995) Nature 375, 599-603. 
136 B.K. Tamarappoo et al. / Biochimica et Biophysica Acta 1279 (1996) 131-136 
[17] Vadgama, J.V. and Christensen, H.N. (1984) J. Biol. Chem. 259, 
3648-3652. 
[18] Makowske, M. and Christensen, H.N. (1982) J. Biol. Chem. 257, 
5663-5670. 
[19] Makowske, M. and Christensen, H.N. (1982) J. Biol. Chem. 257, 
14635-14638. 
[20] Kilberg, M.S. (1989) Methods Enzymol. 173, 564-575. 
[21] Kilberg, M.S., Handlogten, M.E. and Christensen, H.N. (1981) J. 
Biol. Chem. 256, 3304-3312. 
[22] Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156- 
159. 
[23] Church, G. and Gilbert, W. (1984) Proc. Natl. Acad. Sci. USA 81, 
1991-1995. 
[24] Hopp, T.P., Prickett, K.S., Price, V.L., Libby, R.T., March, C.J., 
Cerretti, D.P., Urdal, D.L. and Conlon, P.L. (1988) Biotechnology 6,
1204-1210. 
[25] Laemmli, U.K. (1970) Nature 227, 680-685. 
[26] Chiles, T.C., O'Brien, T.W. and Kilberg, M.S. (1987) Anal. 
Biochem. 163, 136-142. 
[27] Zhang, Y., Pines, G. and Kanner, B.I. (1994) J. Biol. Chem. 269, 
19573-19577. 
[28] Kaback, H.R. (1988) Annu. Rev. Physiol. 50, 243-256. 
[29] Gerchman, Y., Olami, Y., Rimon, A., Taglicht, D., Schuldiner, S. 
and Padan, E. (1993) Proc. Natl. Acad. Sci. USA 90, 1212-1216. 
[30] Shirvan, A., Laskar, O., Steiner-Mordoch, S. and Schuldiner, S. 
(1994) FEBS Lett. 356, 145-150. 
[31] Yu, X., Hoa, L. and Inesi, G. (1994) J. Biol. Chem. 269, 16656- 
16661. 
[32] Arriza, J.L., Fairman, W.A., Wadiche, J.I., Murdoch, G.H., Ka- 
vanaugh, M.P. and Amara, S.G. (1994) J. Neurosci. 14, 5559-5569. 
[33] Kanai, Y., Stelzner, M., Nu/3berger, S., Khawaja, S., Hebert, S.C., 
Smith, C.P. and Hediger, M.A. (1994) J. Biol. Chem. 269, 20599- 
20606. 
[34] Lucus, M. (1983) Gut 24, 734-739. 
[35] Daniel, H., Neugebauer, B., Kratz, A. and Rehner, G. (1985) Am. J. 
Physiol. 248, G293-298. 
[36] Daniel, H., Fett, C. and Kratz, A. (1989) Am. J. Physiol. 257, 
G486-495. 
